![Jason Gardner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Gardner
Amministratore Delegato presso
Ampersand Biomedicines
Profilo
Jason Gardner was the founder of Magenta Therapeutics, Inc., founded in 2015, where the titles held included President, Chief Executive Officer & Director from 2016 to 2023.
Dr. Gardner is currently Chief Executive Officer & Director at Ampersand Biomedicines, Inc. since 2023 and serves as Director at Obsidian Therapeutics, Inc. Former jobs include Scientist at Chiron Corp., Scientist at Progenics Pharmaceuticals, Inc., Vice President at GSK Plc from 2005 to 2015, and Advisor at Atlas Venture Advisors, Inc. Education includes a doctorate from the University of Oxford conferred in 1995 and an undergraduate degree from the University of Cambridge conferred in 1991.
Posizioni attive di Jason Gardner
| Società | Posizione | Inizio |
|---|---|---|
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Direttore/Membro del Consiglio | - |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Amministratore Delegato | 14/08/2023 |
Precedenti posizioni note di Jason Gardner
| Società | Posizione | Fine |
|---|---|---|
| MAGENTA THERAPEUTICS | Fondatore | 07/02/2023 |
| GSK PLC | Corporate Officer/Principal | 01/11/2015 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consulente / Consigliere | - |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | - |
Formazione di Jason Gardner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
94
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Health Technology |
